SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Dr Reddys Laboratories Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
500124 INE089A01023 1361.8538112 DRREDDY 0.63 105,928.76 26.62 238.56 5
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales4083.104819.105420.10
Other Operating Income19.9019.6017.20
Other Income 227.60223.10233.60
Total Income4330.605061.805670.90
Total Expenditure 3446.703209.603209.60
PBIDT883.901852.202461.30
Interest 5.605.804.50
PBDT878.301846.402456.80
Depreciation246.40245.80237.20
Tax156.90396.00538.70
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.2012.0041.50
Reported Profit After Tax475.201192.601639.40
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item475.201192.601639.40
    
EPS (Unit Curr.)28.5571.6898.66
EPS (Adj) (Unit Curr.)28.5571.6898.66
Calculated EPS (Unit Curr.)28.4971.5098.40
Calculated EPS (Adj) (Unit Curr.)28.4971.5098.40
Calculated EPS (Ann.) (Unit Curr.)113.96286.00393.61
Calculated EPS (Adj) (Ann.) (Unit Curr.)113.96286.00393.61
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity83.4083.4083.30
Reserve & Surplus0.000.000.00
Face Value5.005.005.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)21.6538.4345.41
PBDTM(%)21.5138.3145.33
PATM(%)11.6424.7530.25